Focus Point Holdings BhdXKLS:0157 70 ROA % is 10.83% as of Mar. 2026, which is 74% above its 10-year median of 6.22. GuruFocus rates XKLS:0157 with a GF Score™ of 70/100 and a GF Value™ of RM0.67 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 856 Medical Devices & Instruments companies, Focus Point Holdings Bhd ranks better than 89.49% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Focus Point Holdings Bhd's annualizedNet Income for the quarter that ended in Mar. 2026 was RM36.8 Mil.
Focus Point Holdings Bhd's average Total Assets over the quarter that ended in Mar. 2026 was RM339.6 Mil. Therefore, Focus Point Holdings Bhd's annualized ROA % for the quarter that ended in Mar. 2026 was 10.83%.
The historical rank and industry rank for Focus Point Holdings Bhd's ROA % or its related term are showing as below:
XKLS:0157'
s ROA % Range Over the Past 10 Years
Min: -0.93 Med: 6.22 Max: 14.23
Current: 11.15
During the past 13 years, Focus Point Holdings Bhd's highest ROA % was 14.23%. The lowest was -0.93%. And the median was 6.22%.
XKLS:0157's ROA % is ranked better than 89.49% of 856
companies
in the Medical Devices & Instruments industry
Industry Median: 0.545
vs XKLS:0157: 11.15
Focus Point Holdings Bhd (XKLS:0157) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Focus Point Holdings Bhd's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Focus Point Holdings Bhd ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Focus Point Holdings Bhd's ROA % distribution charts can be found below:
* The bar in red indicates where Focus Point Holdings Bhd's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Focus Point Holdings Bhd (XKLS:0157) has a ROA % of 10.83% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Focus Point Holdings Bhd and its competitors. This is 74% above median its historical median of 6.22. According to the industry distribution chart, Focus Point Holdings Bhd ranks #90 out of 856 companies in the Medical Devices & Instruments industry, placing it in the top 10.5%.
Is Focus Point Holdings Bhd's ROA % too high?
Focus Point Holdings Bhd's current ROA % of 10.83% is 74% above median its 10-year median of 6.22. The Medical Devices & Instruments industry median ROA % is 0.55. Focus Point Holdings Bhd's value of 10.83% is 1887.2% above this industry median. Based on the distribution chart, Focus Point Holdings Bhd ranks #90 out of 856 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Focus Point Holdings Bhd has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Focus Point Holdings Bhd's ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Focus Point Holdings Bhd ranks #90 out of 856 companies for ROA %. This places Focus Point Holdings Bhd in the top 11% of its industry — outperforming the majority of peers. The industry median ROA % is 0.55. Focus Point Holdings Bhd's value of 10.83% is 1887.2% above this benchmark. While the company's 10-year median is 6.22 vs. the industry median of 0.55, Focus Point Holdings Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.55, based on 856 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Focus Point Holdings Bhd's current ROA % of 10.83% is 1887.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Focus Point Holdings Bhd and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Focus Point Holdings Bhd's current ROA % is 10.83%, which is 74% above median its own 10-year median of 6.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Focus Point Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Focus Point Holdings Bhd (XKLS:0157) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.67, compared to a current price of RM0.51 — trading 23.9% below its estimated fair value. The current ROA % is 10.83%, which is 74% above median its 10-year median of 6.22 and 1887.2% above the Medical Devices & Instruments industry median of 0.55. Focus Point Holdings Bhd's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Focus Point Holdings Bhd (XKLS:0157), the current ROA % is 10.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Focus Point Holdings Bhd (XKLS:0157) Overvalued in 2026?
Based on GuruFocus' analysis, Focus Point Holdings Bhd stock appears to be undervalued.
The current stock price of RM0.51 is trading 23.9% below its estimated GF Value™ of RM0.67.
GuruFocus considers Focus Point Holdings Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0157:
ROA %: 10.83% (74% above median its 10-year median of 6.22)
GF Value™: RM0.67 vs. price of RM0.51 (23.9% below fair value)
Industry Position: 1887.2% above the Medical Devices & Instruments median (#90 of 856)
No single metric tells the full story. See the XKLS:0157 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Focus Point Holdings Bhd operates professional eye care centres, trading of eyewear and eye care products, investment holding, retail sale of other food products, management of franchised professional eye care centres, provision of medical eye care services, and operation of food and beverages business. The company's operating segments are the Optical segment and the Food and Beverages segment. The firm generates the majority of its revenue from the Optical segment, which is engaged in the retailing of optical and related products, including the management of franchised optical outlets. The food and beverages segment is into the provision of food and beverage services, including the management of franchised food and beverage outlets.
70GF Score
Get the complete analysis for XKLS:0157
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0157 has been successfully added to your 
